India Orders New Trials Of Lundbeck's Deanxit Anti-anxiety Combo
This article was originally published in PharmAsia News
Executive Summary
Indian health authorities said Danish drug maker Lundbeck and Indian makers of generic versions of Deanxit (flupentixol/melitraxen) would be required to conduct new clinical trials of the medicine